CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- 4 Open-market sale Chief Financial Officer sold 3,326 shares at $11.11 ($36,954)
- 4 Open-market sale Co-Chief Executive Officer sold 7,715 shares at $11.09 ($85,596)
- 4 Open-market sale Co-Chief Executive Officer sold 7,715 shares at $11.09 ($85,589)
- 4 Open-market buy Director bought 8,100 shares at $12.45 ($100,845)
- 4 Open-market sale Chief Medical Officer sold 6,580 shares at $14.35 ($94,418)
- 4 Open-market sale Co-Chief Executive Officer sold 29,975 shares at an average $14.38 ($430,952)
- 4 Open-market sale Chief Legal Officer sold 8,828 shares at $14.58 ($128,669)
- 4 Open-market sale Chief Financial Officer sold 10,558 shares at $14.65 ($154,650)
- 4 Open-market sale Co-Chief Executive Officer sold 29,933 shares at an average $14.35 ($429,469)
- 4 Open-market sale Chief Medical Officer sold 12,039 shares at $14.58 ($175,518)
- 4 Planned sale Chief Legal Officer sold 30,000 shares at an average $8.20 ($246,149)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Chief Legal Officer gave 1,000 shares (gift)
- 4 Open-market sale Chief Financial Officer sold 10,896 shares at $3.47 ($37,806)
- 4 Open-market sale Chief Medical Officer sold 12,425 shares at $3.47 ($43,082)
- 4 Open-market sale Chief Legal Officer sold 9,192 shares at $3.48 ($31,954)
Page 3 of 11 · 207 filings